Reproductive Lifespan and Your Genetics

Written by Scott Peeples, BS Biomedical Sciences · ExomeDNA Founder Reviewed by ExomeDNA Editorial Process Last reviewed: May 26, 2026

Reproductive lifespan is the number of years a person ovulates — measured from menarche (first period) through natural menopause. Genetic variants near genes involved in egg-cell maintenance and DNA repair are associated with variation in this window across large population studies.^[1] Inherited factors shape a meaningful share of this variation, interacting with lifestyle and environmental influences. Below: the genetic architecture of this trait, the research base, and what current findings suggest about how ovulatory duration relates to broader health.

What is reproductive lifespan?

Reproductive lifespan is the span of years between first period and natural menopause, during which ovulation occurs monthly. This window varies substantially between people, shaped by both environmental and inherited factors. Genetic variants at multiple chromosomal loci have been associated with differences in its length.

In typical populations, the average reproductive span runs roughly 35 to 42 years — menarche generally occurring in early adolescence and natural menopause around ages 50–51. Both endpoints can be shifted by genetics: earlier menarche or later menopause can extend the span; delayed menarche or early menopause compress it. The total years of ovulation represents a composite of two separately influenced biological processes.

Understanding your reproductive lifespan genetics offers context for where in the typical range your biology is likely to fall — not a prediction of specific dates, but an estimate of the inherited contribution to this window.

The genetics behind reproductive lifespan

The years between menarche and menopause are influenced by variants at dozens of chromosomal loci. The genetic signals for this trait overlap with those for menarche timing and menopause timing studied separately, since reproductive lifespan is their arithmetic difference. Loci near genes involved in DNA repair — including FANCA, FANCI, and MCM8 — are among those implicated in reproductive aging.^[1] These genes are primarily known for maintaining chromosomal integrity during cell division; pathogenic variants in the same genes underlie Fanconi anemia and, in some cases, premature ovarian insufficiency.

Genetic variants associated with years of ovulation were used as Mendelian randomization instruments — natural biological experiments that use inherited variants to test causal relationships between ovulatory duration and downstream health outcomes at population scale.^[1]

A separate cluster of signals involves transcription factors active during early gonadal development. Variants near GCM2 — a transcription factor with roles in germ-cell development — and KDM4A, a chromatin-modifying enzyme involved in gene regulation during oocyte maturation, appear among the loci associated with this trait. These signal that developmental programming of reproductive tissue is a second biological theme beyond DNA maintenance.

Reproductive lifespan GWAS signals have been validated as genetic instruments with sufficient biological specificity to support Mendelian randomization analyses — a standard that requires the genetic variants to have a real, non-confounded relationship with the trait of interest.^[1]

A locus near ACSL1, which encodes a long-chain fatty acid activation enzyme, is also among the genetic signals for this trait. The association may reflect the metabolic demands of follicular development — follicle survival depends on active lipid metabolism — though the specific mechanism linking ACSL1 to ovarian aging remains an open research question.

What the research says

Research base: Moderate. Genome-wide association studies have identified common-variant signals for years of ovulating, and Mendelian randomization analyses have used these signals to examine causal links between ovulatory duration and downstream health outcomes including endometrial cancer risk.^[1] The evidence base for this specific composite trait is more limited than for either endpoint studied separately, where large international consortia have contributed data from tens of thousands of participants. See our methodology page for how genetic evidence is assessed before inclusion in your ExomeDNA profile.

Most large-scale studies in this area have been conducted in European-ancestry populations, with more limited representation from other groups. Effect sizes for individual common variants are modest; the genetic contribution accumulates across many loci. Results from Mendelian randomization studies point toward biological mechanisms rather than clinical predictions for individual outcomes.

How reproductive lifespan affects you

A longer reproductive lifespan means more ovulatory cycles across a lifetime and more years of cyclical estrogen and progesterone exposure. This hormonal environment influences multiple tissues over time. Research using genetic variants for this trait as instruments has linked ovulatory duration to altered endometrial cancer risk, reflecting cumulative hormonal exposure on uterine tissue.^[1] At the other end, shorter reproductive lifespans — particularly those ending in early menopause — are associated with reduced estrogen protection for bone and cardiovascular tissue.

The relationship between reproductive lifespan and health is bidirectional in some respects: conditions that affect ovarian function can shorten the span, while the length of the span independently influences long-term health through hormonal exposure. Research in this area continues to separate the genetic contribution from overlap with underlying reproductive conditions.

The genetic component of your reproductive lifespan is one piece of a larger picture. Body weight, smoking status, thyroid function, oral contraceptive use, and reproductive history all influence actual menopause timing independently of genetics. Your ExomeDNA result reflects the inherited component — not a clinical timeline or a clinical finding.

Working with your reproductive lifespan result

What research suggests about factors related to reproductive timing

• Maintaining a healthy body weight throughout the reproductive years is associated with more regular ovulatory cycles; extremes of leanness or obesity can disrupt hormonal regularity and may influence the pace of ovarian aging.^[1]
• Avoiding smoking is consistently associated with preserved ovarian reserve and later natural menopause onset in population studies — smoking is one of the most replicated modifiable influences on menopause timing.
• Moderate-intensity physical activity appears to support hormonal regularity without the cycle disruption seen at extreme athletic training intensities.
• People who experience early natural menopause may benefit from bone density monitoring sooner, since the post-reproductive period is when estrogen-linked skeletal protection diminishes.
• Reproductive lifespan genetics are most meaningful as biological context alongside your own reproductive history and clinical care — not a standalone guide to health decisions.

Related traits and genes

The genetics of reproductive lifespan connect to several related traits in your ExomeDNA profile. Within reproductive and hormonal health, Age at Menopause addresses the endpoint that most directly determines the upper boundary of your reproductive lifespan — see how your genetics across these two traits compare for a fuller picture of ovarian aging. Menarche Timing covers the lower boundary; variants associated with earlier menarche can extend total ovulatory years independently of menopause age. Fertility Indicators captures aspects of ovarian reserve related to fecundability at a given point within the reproductive window.

Across categories, Bone Density is directly relevant: estrogen exposure during the reproductive years is a key input into bone mineral accumulation over a lifetime. Endometrial Health shares the biological pathway studied in the endometrial cancer Mendelian randomization analyses that underpin this trait's research evidence.

Frequently asked questions

Does my reproductive lifespan result predict when I'll go through menopause?

No — this result reflects the inherited factors associated with years of ovulating, not a clinical prediction of when your periods will end. Natural menopause timing is influenced by genetics, body weight, smoking history, thyroid function, and medical history. Use this result as biological context alongside a full clinical picture, not as a standalone forecast.

Can genetics explain early menopause?

Partially. Rare pathogenic variants in genes like FANCA, FANCI, and MCM8 are known causes of premature ovarian insufficiency — a distinct clinical condition separate from the common-variant genetics measured here. Common GWAS variants associated with reproductive lifespan contribute smaller, additive effects on normal variation. An ExomeDNA result toward the lower end of the range does not indicate premature ovarian insufficiency.

Is a longer reproductive lifespan better for health?

Not categorically. A longer reproductive span means more ovulatory cycles and more years of estrogen exposure — protective for some tissues (bone, cardiovascular) and associated with different cancer risk in others. Context matters: a longer span resulting from late menopause has different implications than one resulting from very early menarche. Research continues to disentangle these relationships across different health outcomes.

Does reproductive lifespan affect fertility?

Indirectly. Ovarian reserve — the remaining supply of egg cells — declines throughout reproductive life, and the rate of this decline has a genetic component related to reproductive lifespan. Reproductive lifespan as measured here (total years ovulating) is not a direct measure of fertility at any single point in time, which depends on many additional factors.

How accurate is a genetic estimate of reproductive lifespan?

Genetic variants explain a portion of the variation in reproductive lifespan; the overall evidence base for this composite trait is rated moderate. Individual predictions carry meaningful uncertainty — the result reflects population-level associations, not individual precision. Consider it a biological baseline, not a clinical forecast.

References

1. D'Urso S, et al. (2022). Mendelian randomization analysis of factors related to ovulation and reproductive function and endometrial cancer risk. BMC Med. PMID: 36320039. DOI: 10.1186/s12916-022-02585-w.

Data sources:

• GWAS Catalog (NHGRI-EBI, accessed 2026-05-26)
• Open Targets Platform (CC0 1.0, accessed 2026-05-26)
• ClinVar (NCBI, accessed 2026-05-26) — entries at ≥2-star review status
• ClinGen Gene-Disease Validity (CC0 1.0, accessed 2026-05-26)

This page is published by the ExomeDNA Research Team. Last reviewed: 2026-05-26.